Table of Contents

1 Study Coverage

• 1.1 Blood Screening Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Blood Screening Market Size Growth Rate by Product
  • 1.4.2 Reagent
  • 1.4.3 Instrument
• 1.5 Market by End User
  • 1.5.1 Global Blood Screening Market Size Growth Rate by End User
  • 1.5.2 Blood Bank
  • 1.5.3 Hospital
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Blood Screening Market Size
  • 2.1.1 Global Blood Screening Revenue 2014-2025
  • 2.1.2 Global Blood Screening Sales 2014-2025
• 2.2 Blood Screening Growth Rate by Regions
  • 2.2.1 Global Blood Screening Sales by Regions
  • 2.2.2 Global Blood Screening Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Blood Screening Sales by Manufacturers
  • 3.1.1 Blood Screening Sales by Manufacturers
  • 3.1.2 Blood Screening Sales Market Share by Manufacturers
  • 3.1.3 Global Blood Screening Market Concentration Ratio (CR5 and HHI)
• 3.2 Blood Screening Revenue by Manufacturers
  • 3.2.1 Blood Screening Revenue by Manufacturers (2014-2019)
  • 3.2.2 Blood Screening Revenue Share by Manufacturers (2014-2019)
• 3.3 Blood Screening Price by Manufacturers
• 3.4 Blood Screening Manufacturing Base Distribution, Product Types
  • 3.4.1 Blood Screening Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Blood Screening Product Type
  • 3.4.3 Date of International Manufacturers Enter into Blood Screening Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Blood Screening Sales by Product
• 4.2 Global Blood Screening Revenue by Product
• 4.3 Blood Screening Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Blood Screening Breakdown Data by End User

6 North America

• 6.1 North America Blood Screening by Countries
  • 6.1.1 North America Blood Screening Sales by Countries
  • 6.1.2 North America Blood Screening Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Blood Screening by Product
• 6.3 North America Blood Screening by End User

7 Europe

• 7.1 Europe Blood Screening by Countries
  • 7.1.1 Europe Blood Screening Sales by Countries
  • 7.1.2 Europe Blood Screening Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Blood Screening by Product
• 7.3 Europe Blood Screening by End User

8 Asia Pacific

• 8.1 Asia Pacific Blood Screening by Countries
  • 8.1.1 Asia Pacific Blood Screening Sales by Countries
  • 8.1.2 Asia Pacific Blood Screening Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Blood Screening by Product
• 8.3 Asia Pacific Blood Screening by End User

9 Central & South America

• 9.1 Central & South America Blood Screening by Countries
  • 9.1.1 Central & South America Blood Screening Sales by Countries
  • 9.1.2 Central & South America Blood Screening Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Blood Screening by Product
• 9.3 Central & South America Blood Screening by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Blood Screening by Countries
  • 10.1.1 Middle East and Africa Blood Screening Sales by Countries
  • 10.1.2 Middle East and Africa Blood Screening Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Blood Screening by Product
• 10.3 Middle East and Africa Blood Screening by End User

11 Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Abbott Laboratories Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Abbott Laboratories Blood Screening Products Offered
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Alere Inc.
  • 11.2.1 Alere Inc. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Alere Inc. Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Alere Inc. Blood Screening Products Offered
  • 11.2.5 Alere Inc. Recent Development
• 11.3 Apex Biotechnology Corp.
  • 11.3.1 Apex Biotechnology Corp. Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Apex Biotechnology Corp. Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Apex Biotechnology Corp. Blood Screening Products Offered
  • 11.3.5 Apex Biotechnology Corp. Recent Development
• 11.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
  • 11.4.1 Beckman Coulter (A Subsidiary of Danaher Corporation) Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Products Offered
  • 11.4.5 Beckman Coulter (A Subsidiary of Danaher Corporation) Recent Development
• 11.5 Becton, Dickinson and Company
  • 11.5.1 Becton, Dickinson and Company Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Becton, Dickinson and Company Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Becton, Dickinson and Company Blood Screening Products Offered
  • 11.5.5 Becton, Dickinson and Company Recent Development
• 11.6 Biomrieux
  • 11.6.1 Biomrieux Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Biomrieux Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Biomrieux Blood Screening Products Offered
  • 11.6.5 Biomrieux Recent Development
• 11.7 Bio-Rad Laboratories, Inc.
  • 11.7.1 Bio-Rad Laboratories, Inc. Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Bio-Rad Laboratories, Inc. Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Bio-Rad Laboratories, Inc. Blood Screening Products Offered
  • 11.7.5 Bio-Rad Laboratories, Inc. Recent Development
• 11.8 F. Hoffmann-La Roche
  • 11.8.1 F. Hoffmann-La Roche Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 F. Hoffmann-La Roche Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 F. Hoffmann-La Roche Blood Screening Products Offered
  • 11.8.5 F. Hoffmann-La Roche Recent Development
• 11.9 Grifols
  • 11.9.1 Grifols Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Grifols Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Grifols Blood Screening Products Offered
  • 11.9.5 Grifols Recent Development
• 11.10 Hem
  • 11.10.1 Hem Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Hem Blood Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Hem Blood Screening Products Offered
  • 11.10.5 Hem Recent Development

12 Future Forecast

• 12.1 Blood Screening Market Forecast by Regions
  • 12.1.1 Global Blood Screening Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Blood Screening Revenue Forecast by Regions 2019-2025
• 12.2 Blood Screening Market Forecast by Product
  • 12.2.1 Global Blood Screening Sales Forecast by Product 2019-2025
  • 12.2.2 Global Blood Screening Revenue Forecast by Product 2019-2025
• 12.3 Blood Screening Market Forecast by End User
• 12.4 North America Blood Screening Forecast
• 12.5 Europe Blood Screening Forecast
• 12.6 Asia Pacific Blood Screening Forecast
• 12.7 Central & South America Blood Screening Forecast
• 12.8 Middle East and Africa Blood Screening Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Blood Screening Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Blood Screening market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Blood Screening market based on company, product type, end user and key regions.

This report studies the global market size of Blood Screening in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Screening in these regions.
This research report categorizes the global Blood Screening market by top players/brands, region, type and end user. This report also studies the global Blood Screening market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Alere Inc.
Apex Biotechnology Corp.
Beckman Coulter (A Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
Biomrieux
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche
Grifols
Hem

Market size by Product
Reagent
Instrument
Market size by End User
Blood Bank
Hospital

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Blood Screening market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Blood Screening market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Screening companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Screening submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Blood Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Screening market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.